Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000939767-26-000098
Filing Date
2026-08-05
Accepted
2026-08-05 16:13:51
Documents
76
Period of Report
2026-07-03

Document Format Files

Seq Description Document Type Size
1 10-Q exel-20260703.htm   iXBRL 10-Q 1322206
2 EX-10.2 exelixis-nonxemployeedirec.htm EX-10.2 58568
3 EX-31.1 exel20260630exhibit311_q226.htm EX-31.1 9476
4 EX-31.2 exel20260636exhibit312_q226.htm EX-31.2 9456
5 EX-32.1 exel20260630exhibit321_q226.htm EX-32.1 6781
11 exel-20260703_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-26-000098.txt   7343766

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20260703.xsd EX-101.SCH 50047
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20260703_cal.xml EX-101.CAL 73830
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20260703_def.xml EX-101.DEF 222603
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20260703_lab.xml EX-101.LAB 577533
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20260703_pre.xml EX-101.PRE 402586
80 EXTRACTED XBRL INSTANCE DOCUMENT exel-20260703_htm.xml XML 1122192
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0101
Type: 10-Q | Act: 34 | File No.: 000-30235 | Film No.: 261243682
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)